Mpox clinical trials at University of California Health
2 in progress, 0 open to eligible people
Showing trials for
Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults
Sorry, in progress, not accepting new patients
A multicenter, randomized, parallel-group, placebo-controlled, double-blind, Phase 1/2a clinical study to investigate the safety, tolerability, immunogenicity and exploratory efficacy of a vaccine regimen consisting of an Ad26.Mos4.HIV prime and a…
at UCLA
Tecovirimat for Human Mpox Virus
Sorry, in progress, not accepting new patients
A5418 is a randomized, placebo-controlled, double-blind study to establish the efficacy of tecovirimat for the treatment of people with laboratory-confirmed or presumptive HMPXV disease.
at UC Davis UCLA UCSD UCSF
Last updated: